Search research articles
Contact Us
Filters
Showing results (11-20 of 62) with videos related to
Page
of 7
Sort By:
European Journal of Cancer Care
|
February 14, 2004
Communicating suffering in primary stage head and neck cancer
R J Moore, R M Chamberlain, F R Khuri
The Yale Journal of Biology and Medicine
|
April 2, 2002
A voice that wraps around the body--communication problems in the advanced stages of non-small cell lung cancer
R J Moore, R M Chamberlain, F R Khuri
Journal of Clinical Pharmacy and Therapeutics
|
August 3, 2006
Chronic myelomonocytic leukaemia after platinum-based therapy for non-small cell lung cancer: case report and review of the literature
K B Kim, S Faderl, C S Hwang, et al.
Oncogene
|
April 21, 2015
Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells
S Li, Y-T Oh, P Yue, et al.
Journal of the National Cancer Institute
|
February 5, 1997
Molecular epidemiology and retinoid chemoprevention of head and neck cancer
F R Khuri, S M Lippman, M R Spitz, et al.
Oncogene
|
November 26, 2009
Dual engagement of 14-3-3 proteins controls signal relay from ASK2 to the ASK1 signalosome
L M Cockrell, M C Puckett, E H Goldman, et al.
Seminars in Oncology
|
August 22, 2000
Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions
F R Khuri, D M Shin, B S Glisson, et al.
Seminars in Oncology
|
May 13, 1998
Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
D M Shin, B S Glisson, F R Khuri, et al.
Ethnicity & Health
|
November 8, 2001
Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx
R J Moore, D A Doherty, K A Do, et al.
Oncogene
|
April 12, 2011
Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway
C Li, S Fan, T K Owonikoko, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 62) with videos related to
Sort By:
Page
of 7
European Journal of Cancer Care
|
February 14, 2004
Communicating suffering in primary stage head and neck cancer
R J Moore, R M Chamberlain, F R Khuri
The Yale Journal of Biology and Medicine
|
April 2, 2002
A voice that wraps around the body--communication problems in the advanced stages of non-small cell lung cancer
R J Moore, R M Chamberlain, F R Khuri
Journal of Clinical Pharmacy and Therapeutics
|
August 3, 2006
Chronic myelomonocytic leukaemia after platinum-based therapy for non-small cell lung cancer: case report and review of the literature
K B Kim, S Faderl, C S Hwang, et al.
Oncogene
|
April 21, 2015
Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells
S Li, Y-T Oh, P Yue, et al.
Journal of the National Cancer Institute
|
February 5, 1997
Molecular epidemiology and retinoid chemoprevention of head and neck cancer
F R Khuri, S M Lippman, M R Spitz, et al.
Oncogene
|
November 26, 2009
Dual engagement of 14-3-3 proteins controls signal relay from ASK2 to the ASK1 signalosome
L M Cockrell, M C Puckett, E H Goldman, et al.
Seminars in Oncology
|
August 22, 2000
Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions
F R Khuri, D M Shin, B S Glisson, et al.
Seminars in Oncology
|
May 13, 1998
Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
D M Shin, B S Glisson, F R Khuri, et al.
Ethnicity & Health
|
November 8, 2001
Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx
R J Moore, D A Doherty, K A Do, et al.
Oncogene
|
April 12, 2011
Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway
C Li, S Fan, T K Owonikoko, et al.
Page
of 7